Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,407,984
-
Share change
-
+5,214,935
-
Total reported value
-
$54,149,893
-
Put/Call ratio
-
29%
-
Price per share
-
$2.79
-
Number of holders
-
71
-
Value change
-
+$14,502,980
-
Number of buys
-
39
-
Number of sells
-
24
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q1 2021
As of 31 Mar 2021,
RECRO PHARMA INC - COM (SCTL) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,407,984 shares.
The largest 10 holders included
Athyrium Capital Management, LP, Portolan Capital Management, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MAK CAPITAL ONE LLC, VANGUARD GROUP INC, Rubric Capital Management LP, STEPHENS INC /AR/, Alyeska Investment Group, L.P., and Parkman Healthcare Partners LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.